Search

Search Results

1. Neue molekulare Therapien beim nichtkleinzelligen Lungenkarzinom am Beispiel der EGFR/HER1-Inhibition

   Background:

   Lung cancer is one of the most common forms of cancer in western industrialized countries. Patients with advanced non-small cell lung...

   Martin Reck, Anne L. Kranich, ... Ulrich Gatzemeier in Medizinische Klinik

   Article 01 December 2005

2. Aktuelle morphologische Diagnostik bösartiger Lungentumoren

   The histological classification of lung tumors is based upon the 2004 WHO classification. Small cell lung cancer (SCLC) is primarily treated by means...

   K. Junker in Der Pathologe

   Article 01 March 2006
   

3. Prognosefaktoren beim Lungenkarzinom

   Lung cancer still has a poor prognosis. In order to apply an adequate type and degree of therapy, factors of prognostic relevance are needed. Apart...

   R. M. Huber in Der Pneumologe

   Article 01 March 2005

4. Multimodale Therapie des lokal fortgeschrittenen NSCLC

   Patients with locally advanced non-small cell lung cancer (stage IIIB, inoperable stage IIIA) require multimodal therapy. This stage is diagnosed in...

   R. M. Huber, A. Theis in Der Pneumologe

   Article 01 July 2005
   

5. Erlotinib in der Second-Line-Therapie nichtkleinzelliger Lungenkarzinome

   The limited effectiveness of monochemotherapy as second-line therapy for non-small cell lung cancer (NSCLC) requires the development of new...

   M. Wolf in Der Onkologe

   Article 01 July 2005
   

6. Tumorklassifikationen

   The correct use of tumor classifications is one of the key elements of adequate oncological treatment. Tumor classifications comprise: localization,...

   C. Wittekind, I. Tischoff in Der Pathologe

   Article 01 November 2004
   

7. Aktuelle Entwicklungen in der Therapie von Knochenmetastasen

   In the treatment of bone metastases, interdisciplinary approaches are very important. The goals of therapy are alleviation of pain with improved...

   M. Bremer, P.-U. Tunn, ... J. H. Karstens in Der Onkologe

   Article 01 May 2004
   

8. DEGRO 2004

   Thomas G. Wendt, G. Gademann, ... D. Isik in Strahlentherapie und Onkologie

   Article 01 June 2004

9. Apoptose und Tumorregression bei neoadjuvant behandelten lokal fortgeschrittenen nichtkleinzelligen Lungenkarzinomen

   Dysregulation of apoptosis is closely associated with malignant cell transformation. On the other hand, apoptosis is induced by chemotherapy or...

   K. Junker, K.-M. Müller, ... M. Thomas in Der Pathologe

   Article 13 March 2003
   

10. Neoadjuvante Therapie des nichtkleinzelligen Lungenkarzinoms

    In the course of a prospective multicenter study, 40 (26 squamous cell and 14 adenocarcinomas) patients with stage IIIA and IIIB non-small cell lung...

    K. Langner, M. Thomas, ... K. Junker in Der Chirurg

    Article 01 January 2003

11. Chemotherapie

    H.J. Illiger, W. Achenbach in Der Onkologe

    Article 01 May 2001

12. Topotecan

    R. Kath, H. D. Peters, ... K. Höffken in Der Onkologe

    Article 01 June 1998

13. Vorträge

    in Strahlentherapie und Onkologie

    Article 01 November 1997